{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:29:43Z","timestamp":1784262583721,"version":"3.55.0"},"reference-count":35,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T00:00:00Z","timestamp":1479686400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Polio cases due to wild virus are reported by only three countries in the world. Poliovirus type 2 has been globally eradicated and the last detection of poliovirus type 3 dates to November 2012. Poliovirus type 1 remains the only circulating wild strain; between January and September 2016 it caused 26 cases (nine in Afghanistan, 14 in Pakistan, three in Nigeria). The use of oral polio vaccine (OPV) has been the key to success in the eradication effort. However, paradoxically, moving towards global polio eradication, the burden caused by vaccine-derived polioviruses (VDPVs) becomes increasingly important. In this paper circulation of both wild virus and VDPVs is reviewed and implications for the polio eradication endgame are discussed. Between April and May 2016 OPV2 cessation has been implemented globally, in a coordinated switch from trivalent OPV to bivalent OPV. In order to decrease the risk for cVDPV2 re-emergence inactivated polio vaccine (IPV) has been introduced in the routine vaccine schedule of all countries. The likelihood of re-emergence of cVDPVs should markedly decrease with time after OPV cessation, but silent circulation of polioviruses cannot be ruled out even a long time after cessation. For this reason, immunity levels against polioviruses should be kept as high as possible in the population by the use of IPV, and both clinical and environmental surveillance should be maintained at a high level.<\/jats:p>","DOI":"10.1017\/s0950268816002569","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T03:35:17Z","timestamp":1479699317000},"page":"413-419","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":36,"title":["Wild and vaccine-derived poliovirus circulation, and implications for polio eradication"],"prefix":"10.1017","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3181-8054","authenticated-orcid":false,"given":"P. L.","family":"LOPALCO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2016,11,21]]},"reference":[{"key":"S0950268816002569_ref15","first-page":"855","article-title":"Public Health Dispatch: Update: outbreak of poliomyelitis \u2013 Dominican Republic and Haiti, 2000\u20132001","volume":"50","year":"2001","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S0950268816002569_ref24","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2013.18.38.20586"},{"key":"S0950268816002569_ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1537-8"},{"key":"S0950268816002569_ref28","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.19.19566-en","article-title":"Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage","volume":"15","author":"Roivainen","year":"2010","journal-title":"Eurosurveillance"},{"key":"S0950268816002569_ref8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu184"},{"key":"S0950268816002569_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2006.02.005"},{"key":"S0950268816002569_ref3","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-73-12-3065"},{"key":"S0950268816002569_ref10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq140"},{"key":"S0950268816002569_ref4","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009924"},{"key":"S0950268816002569_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.02.071"},{"key":"S0950268816002569_ref33","doi-asserted-by":"publisher","DOI":"10.3201\/eid2210.151071"},{"key":"S0950268816002569_ref14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu295"},{"key":"S0950268816002569_ref32","unstructured":"WHO. Statement on the 10th IHR Emergency Committee regarding the international spread of poliovirus (http:\/\/www.who.int\/mediacentre\/news\/statements\/2016\/10th-ihr-emergency\/en\/). Accessed 20 September 2106."},{"key":"S0950268816002569_ref2","unstructured":"Polio Global Eradication Initiative. Wild poliovirus type 1 and circulating vaccine-derived poliovirus cases (http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek.aspx#sthash.1c50b7hA.dpuf). Accessed 21 September 2016."},{"key":"S0950268816002569_ref6","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.5.1105"},{"key":"S0950268816002569_ref9","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00277-16"},{"key":"S0950268816002569_ref1","unstructured":"Polio Global Eradication Initiative. Global eradication of wild poliovirus type 2 declared (http:\/\/www.polioeradication.org\/mediaroom\/newsstories\/Global-eradication-ofwild-poliovirus-type-2-declared\/tabid\/526\/news\/1289\/Default.aspx#sthash.TWdccMBL.dpuf). Accessed 31 May 2016."},{"key":"S0950268816002569_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00703-0"},{"key":"S0950268816002569_ref27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01174-13"},{"key":"S0950268816002569_ref12","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.20.10994-11005.2003"},{"key":"S0950268816002569_ref23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit838"},{"key":"S0950268816002569_ref31","unstructured":"WHO. WHO statement on the meeting of the International Health Regulations Emergency Committee concerning the international spread of wild poliovirus (http:\/\/www.who.int\/mediacentre\/news\/statements\/2014\/polio-20140505\/en\/). Accessed 30 May 2016."},{"key":"S0950268816002569_ref20","unstructured":"Polio Global Eradication Initiative. Polio public health emergency (http:\/\/www.polioeradication.org\/Keycountries\/PolioEmergency.aspx). Accessed 30 May 2016."},{"key":"S0950268816002569_ref13","doi-asserted-by":"publisher","DOI":"10.3390\/v3081460"},{"key":"S0950268816002569_ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003433"},{"key":"S0950268816002569_ref11","first-page":"1002","article-title":"Update on vaccine-derived polioviruses worldwide, January 2008\u2013June 2009","volume":"58","year":"2009","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S0950268816002569_ref29","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008836"},{"key":"S0950268816002569_ref30","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008820"},{"key":"S0950268816002569_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00064-X"},{"key":"S0950268816002569_ref18","unstructured":"Polio Global Eradication Initiative. Circulating vaccine-derived polioviruses. (http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Circulatingvaccinederivedpoliovirus.aspx). Accessed 30 May 2016."},{"key":"S0950268816002569_ref22","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112666"},{"key":"S0950268816002569_ref21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/AEM.49.4.778-781.1985","article-title":"Virus persistence in groundwater","volume":"49","author":"Yates","year":"1985","journal-title":"Applied and Environmental Microbiology"},{"key":"S0950268816002569_ref34","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.11.30169"},{"key":"S0950268816002569_ref17","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.15.8366-8377.2003"},{"key":"S0950268816002569_ref19","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6518a4"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268816002569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T06:45:58Z","timestamp":1657781158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268816002569\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,21]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0950268816002569"],"URL":"https:\/\/doi.org\/10.1017\/s0950268816002569","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,21]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2016\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}